Mycobacterium bovis Bacille Calmette–Guérin (BCG) is the only vaccine which can currently counter tuberculosis, existed for over 80 years and is one of the most widely used vaccines in current days.
BCG is an M. bovis attenuated strain that was developed, culminating to 13 years of continuous in vitro research, BCG vaccine is given to prevent TB (tuberculosis). The World Health Organisation (WHO) endorses the immunisation of infants soon after birth as possible in all countries with a high risk of tuberculosis infection.
No country in the world today, rich or poor, can claim to be free of tuberculosis.
Tuberculosis is a major health concern globally that claims almost 20 lakhs of lives annually, with developing countries bearing the major brunt of the disease. In March 1993, the WHO declared tuberculosis a "global public health emergency". The situation has deteriorated to great extent due to the emergence of multidrug-resistant tuberculosis and human immunodeficiency virus infection. A fourth of the global population gets latently infected with tuberculosis, and 5 -10% of this latently infected group develops active disease during their lifetime.
The burden of tuberculosis morbidity and mortality in the world as a whole impinges most heavily on developing countries and disproportionately on the poor and other disadvantaged subpopulations of better-resourced countries.
The only available tuberculosis therapy is Directly Observed Treatment Short - course (DOTS), which is very lengthy and possesses various side effects, including the dampening of immune responses resulting in the vulnerability to TB reactivation and reinfection.
At present, the evolving medical research actively seeks an answer in the field of immunology and vaccinology for a permanent or near-permanent solution to curb the growth of the ailment.
After years of intensive research, the BCG vaccine, which was innovated in 1921, still in remains the most widely used vaccine until today despite its limitations and highly variable efficacy.
BCG vaccine full form - Bacille Calmette-Guerin vaccine
The BCG vaccine discovered by Léon Charles Albert Calmette and Jean-Marie Camille Guérin of the first vaccine against tuberculosis disease. The BCG vaccine, named after its discoverers - Calmette and Guerin, at the Institut Pasteur (Pasteur Institute) in Paris, France. Léon Charles Albert Calmette was a French physician, bacteriologist and immunologist and Jean-Marie Camille Guérin was a French veterinarian, bacteriologist and immunologist.
BCG Vaccine was developed from a live-attenuated strain of Mycobacterium bovis, a subspecies of M. tuberculosis. They discovered that the addition of beef bile reduces the clumping in M. bovis and decreases the virulence of the strain.
Clinical immunisation with the BCG vaccine started in Europe as early as 1921. By the 1940s, several studies established the protective role of the BCG vaccine in tuberculosis among children. As the tuberculosis rates increased after World War II, several international health organisations recommended BCG vaccination among the population. In 1948 BCG vaccine was introduced in India, which spread to schools in almost all states of India by 1949. A 2022 study demonstrated that the BCG vaccine also provided protective efficacy against a likely symptomatic COVID-19 infection.
There are a lot of benefits of BCG vaccine for newborns and infants when compared with adults. BCG Vaccine can be given to the following populations:
For children over one year of age and adults, 0.1 ml of vaccine can be given. A single dose is enough to provide lifetime immunity from TB (tuberculosis)
The BCG vaccine can be administered intradermally.
BCG vaccine standard dose at birth is 0.1 mg in 0.1 ml. Few studies show half the dose for newborns. BCG vaccination should be given at birth. Some studies demonstrate increased tuberculin conversion after 1-3 months.
The BCG vaccine scar can range from 2-8 mm in size. Its measurement has no relation to induced immunity and is usually related to wheal size.
BCG Vaccinations cannot be administered to any immunocompromised patients as BCG is a live vaccination. Reduction of immunity can be due to various reasons, such as:
Similar to every other vaccine, the BCG vaccine can also cause side effects, but usually they are mild and not commonly occurred. The side effects of BCG vaccine include:
The most common complication of BCG vaccination is the Injection site reaction, which could include:
The World Health Organisation recommended that BCG vaccines for newborns with a single intradermal dose can be given as soon after birth as possible in all countries with a high risk of tuberculosis infection.
Only one dose of BCG vaccine is given at birth which is sufficient to provide lifetime immunity. Although there are booster doses, they are not recommended by the World Health Organisation. If the baby is under 1 year of age, 0.05 ml of BCG vaccine is given and for over age and adults, 0.1 ml vaccine is given.
BCG vaccine is primarily given to neonates to provide protection against tuberculosis.
The BCG vaccine is given in the left arm just under the skin (intradermal injection). This is the site recommended for immunisation of BCG. It is done so as to identify the immunisation in the future by identifying a small harmless scar that develops after BCG vaccination.
When the healthcare personnel performs annual surveillance campaigns, the babies without the scar are usually considered for vaccinations, which they might have missed an earlier year.
A small spot at the site of the injection which turns into a blister in 2-6 weeks can be expected after BCG vaccine. It gradually develops into a crusty scab and finally into a small scar. It's necessary to leave the area uncovered as aeration can help in healing.
Yes. Injections are painful, and just because they are newborn babies doesn’t mean they can’t feel pain. Nevertheless, it must be rationalised that a moment of pain does not hold a good leverage point against the risk of a potentially debilitating disease. As the injection is done intradermally (under the skin) and considering the minute quantities of the vaccine (0.05 ml for Infants under one year of age), the injection is very quick.
By clicking on subscribe now, you accept to receive communications from PACE Dandle on email, SMS and Whatsapp.
Thank you for contacting us. We will get back to you as soon as possible. Kindly save these contact details in your contacts to receive calls and messages:-
Appointment Desk: 04048486868
Whatsapp: 8977889778
Regards,
Pace Hospitals
Hitech City, Hyderabad,
Telangana, India.
Oops, there was an error sending your message. Please try again later. We will get back to you as soon as possible. Kindly save these contact details in your contacts to receive calls and messages:-
Appointment Desk: 04048486868
Whatsapp: 8977889778
Regards,
PACE Dandle
Hitech City, Hyderabad,
Telangana, India.
PACE Dandle
(A Unit of PACE Hospitals)
Beside Hitech City Metro Station, Hitech City, Madhapur, Hyderabad, Telangana, India - 500081
E: info@pacedandle.com